Loading organizations...
§ Venture Capital · 2 N. Riverside Plaza, Suite 1240, Chicago, IL 60606
An equity holding company, potentially active in private investments, real estate, and broader asset management.
A&B Equity Holdings operates as a private investment firm, deploying capital into promising ventures. Its core activity involves strategic equity investments, primarily focusing on the life sciences, biotechnology, and pharmaceutical sectors. The firm aims to support the development and commercialization of innovative medical solutions, identifying enterprises with significant potential for advancement.
The firm was founded by Ann Lurie, who serves as its manager and holds sole power over its investment and disposition decisions. While a precise founding date is not widely publicized, A&B Equity Holdings has been active in venture capital since at least the mid-2010s, reflecting an insight into the need for dedicated capital partners within high-growth scientific fields.
A&B Equity Holdings serves as a capital partner for emerging and growth-stage companies within its target industries. Its long-term vision centers on fostering innovation and accelerating breakthroughs in healthcare. The firm provides critical financial support and strategic guidance to enterprises developing novel therapies and technologies, contributing to impactful progress in patient care.
A&B Equity Holdings has 1 tracked investment across 1 company. The latest tracked deal is $28.0M Series D in Innocrin Pharmaceuticals in April 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 14, 2015 | Innocrin Pharmaceuticals | $28.0M Series D | Fred Eshelman | Hatteras Venture Partners, Intersouth Partners, Lilly Ventures, Novartis |